Navigation Links
Drug Combinations Putting Seniors at Risk
Date:12/23/2008

sed survey data collected on more than 3,000 adults aged 57 to 85. The researchers looked for all medications, both over-the-counter and prescription, used between June 2005 and March 2006.

The researchers found that 91 percent of U.S. adults, about 50.5 million, used at least one medication regularly. Prescription medicines were used by 81 percent of adults, or 44.9 million older Americans. Most medications were used by those 75 to 85 years old.

In addition, almost 50 percent of older adults used at least one over-the-counter medication or dietary supplement. More women than men used prescription medications and dietary supplements. However, the use of over-the-counter medications was the same for men and women, the researchers found.

More than 50 percent of those surveyed used five or more prescription drugs, over-the-counter medications or dietary supplements. Among those taking prescription medications, 29 percent used more than five drugs and drug use increased with age among both men and women, Qato's group reports.

In addition, the researchers found that 68 percent of older adults used prescription drugs plus over-the-counter medications or dietary supplements. Among those combining drugs, 4 percent were in danger of having an adverse drug reaction.

Moreover, the rate of adverse drug interactions increased with age, particularly among women. Over 50 percent of these interactions involved the use of over-the-counter medications, the researchers found.

The most common adverse interactions occurred with blood thinners such as warfarin and antiplatelet drugs such as aspirin, Qato's group found.

"Physicians and pharmacists need to ask older patients about all the medications they use -- prescription and nonprescription -- and patients need to be prepared to share this information," Qato said. "This is especially important in patients who see multiple providers and patients that fill at multiple
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Do bacterial combinations result in enhanced cytokine production? No!
2. Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
3. AUDIO from Medialink and P&G: Putting Your Smile in Hollywoods Spotlight
4. Putting risk in perspective: Do people make better decisions when they understand average risk?
5. Putting on Pedometer Helps Walkers Shed Pounds
6. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
7. Putting an End to Medical Cruelty: A Horrifying Article in Yahoo this Week by T. L. Kittle
8. U.S. Soccer Team Putting Vision in Focus for the Beijing 2008 Olympic Games
9. VA Putting Mobile Pharmacies on the Road
10. Targeting aggressive breast cancers by putting them to sleep
11. Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Combinations Putting Seniors at Risk
(Date:7/22/2014)... July 22, 2014 Dimension One Spas’ ... 24 months on all models during the “Let’s Take ... Please visit http://www.d1spas.com/financing for more information and ... Dimension One Spas offers a wide variety of outdoor ... lights, fountains, waterfalls, music, customizable massage, and personal controls. ...
(Date:7/22/2014)... July 22, 2014 Over the ... almost every sphere of human anatomy. In the ... advancements that rendered the possibility of deploying certain ... blood and tissues, in order to detect the ... abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the ...
(Date:7/22/2014)... Steven Reinberg HealthDay ... Simple blood tests may one day help predict survival and ... sclerosis (ALS), also called Lou Gehrig,s disease, Italian researchers report. ... clues to how fast ALS is progressing are called albumin ... and liver health, according to the U.S. National Library of ...
(Date:7/22/2014)... of coffee and sit down to read People magazine. How ... you reach for another cup? Would you need more caffeine ... study in the Journal of Consumer Research finds ... and aspirin lose their effectiveness when they engage in more ... it takes for products to wear off. For example, they ...
(Date:7/22/2014)... an astronaut is a much-studied thing. Scientists have analyzed ... even matters of the heart. But for the first ... inflammation caused by the conditions of space flight affect ... fly on the International Space Station. Lessons learned may ... Oxidative stress reflects an imbalance in the body,s ability ...
Breaking Medicine News(10 mins):Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:Why do challenging tasks make consumers believe drugs wear off faster? 2Health News:The heart of an astronaut, five years on 2Health News:The heart of an astronaut, five years on 3
... ... Foundation has teamed up with Pilot Pen to create a line of ... Breast Cancer Foundation is a nonprofit committed to providing direct financial assistance ... early detection and survival of breast cancer. To show support Pilot Pen ...
... ... Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the release of ... ... -- Purity Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the ...
... Research suggests millions are going without needed medical services , ... a history of cancer, particularly people under age 65, are ... the cost of treatment, a new study suggests. , ... quality of life of the 12 million adults in the ...
... ... with the modern and hits big on iTunes store first days of launch , ... New York, NY (PRWEB) June 14, 2010 -- 2010 ... “The Karate Kid”, two events bringing renewed popular interest in Chinese martial arts. , , , ...
... ... of the dangers of cycling injuries and urges caution on the roads , ... (PRWEB) June 14, 2010 -- National Accident Helpline is urging ... weather is seeing an increasing number of people take to their bikes, often for the first ...
... ... production assets, inventory and certain information of the Cell-Pore product group previously owned and ... ... today that it has completed its purchase of the principal manufacturing and production assets, ...
Cached Medicine News:Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 2Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 3Health News:Purity Products Releases Ultimate Sleep Plus Melatonin 2Health News:Cost-Conscious Cancer Survivors Skip Care 2Health News:Cost-Conscious Cancer Survivors Skip Care 3Health News:New iPhone App “Wing Chun Masters” Brings 400-Year-Old Kung Fu To Life Amidst Renewed Popular Interest In Culture. 2Health News:New iPhone App “Wing Chun Masters” Brings 400-Year-Old Kung Fu To Life Amidst Renewed Popular Interest In Culture. 3Health News:Break The Injury Cycle, Says National Accident Helpline 2Health News:CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics 2
(Date:7/22/2014)... July 22, 2014 BioDelivery Sciences International, Inc. ... Board of Directors has appointed Charles J. (Chuck) ... as members of the Board.  Mr. ... experience in marketing, sales and other commercial functions.  He ... Inc., a development stage company that was recently acquired ...
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), a ... on commercialization of its non-invasive Monarch ™ ... neuropsychiatric disorders, today announced that enrollment has begun in ... stimulation (eTNS) as adjunctive therapy for the treatment of ... conducted at the Olive View-UCLA Medical Center in ...
(Date:7/21/2014)... ANGELES , July 21, 2014 /PRNewswire-iReach/ -- Nitrosolution.com, ... oxide supplements , will celebrate its first anniversary in ... that is designed to enhance the body,s ability to ... formula that is made up of a variety of ... said have been found to increase nitric oxide ...
Breaking Medicine Technology:BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2
... -First Combination Study of a MET and EGFR Inhibitor-, ... (Nasdaq: EXEL ) today announced that it has ... non-small cell lung cancer (NSCLC) who have had,progressive disease ... a small molecule that simultaneously inhibits the MET, RET ...
... ASHBURN, Va., Jan. 4 Innocoll, Inc., ... first of a series of,planned phase 2 ... subsidiary,Innocoll Technologies Ltd, to investigate CollaRx(R) BUPIVACAINE ... has commenced dosing., Innocoll,s BUPIVACAINE SURGICAL ...
Cached Medicine Technology:Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 2Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 3Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 4Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4